Nature Medicine, Published online: 22 September 2026; doi:10.1038/s41591-026-04656-4
In a large-scale study, a new tool called Esophageal AI-Guided malignant Lesion Evaluation uses artificial intelligence to enhance esophageal cancer detection through noncontrast computed tomography, achieving high sensitivity and specificity across diverse settings.
